Publications by authors named "So Ueda"

Claim this Profile
F
Fulminant type 1 diabetes mellitus with anti-programmed cell death-1 therapy.
Masahide Okamoto, Mitsuhiro Okamoto, Koro Gotoh, Takayuki Masaki, Yoshinori Ozeki, So Ueda

J Diabetes Investig· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum levels of advanced glycation end products (AGEs) are inversely associated with the number and migratory activity of circulating endothelial progenitor cells in apparently healthy subjects.
So Ueda, Sho-ichi Yamagishi, Takanori Matsui, Yoshihiro Noda, Shin-ichiro Ueda

Cardiovasc Ther· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum pigment epithelium-derived factor levels are independently associated with decreased number of circulating endothelial progenitor cells in healthy non-smokers.
Sho-Ichi Yamagishi, Sayaka Maeda, So Ueda, Yuji Ishibashi, Takanori Matsui

Int J Cardiol· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pigment epithelium-derived factor (PEDF) inhibits diabetes- or advanced glycation end product (AGE)-induced platelet CD40 ligand overexpression in rats.
Sho-ichi Yamagishi, Takanori Matsui, So Ueda, Masayoshi Takeuchi

Int J Cardiol· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The p66shc gene expression in peripheral blood monocytes is increased in patients with coronary artery disease.
Yoshihiro Noda, Sho-ichi Yamagishi, Takanori Matsui, So Ueda, Shin-ichiro Ueda

Clin Cardiol· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pigment epithelium-derived factor (PEDF): its potential therapeutic implication in diabetic vascular complications.
Sho-Ichi Yamagishi, Takanori Matsui, Kazuo Nakamura, So Ueda, Yoshihiro Noda

Curr Drug Targets· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibitors of advanced glycation end products (AGEs): potential utility for the treatment of cardiovascular disease.
Sho-ichi Yamagishi, Kazuo Nakamura, Takanori Matsui, So Ueda, Yoshihiro Noda

Cardiovasc Ther· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis